Designing Pharma organisations for success

Individualized, precision medicine is an evolving medical model and is key in helping clinicians reach accurate diagnoses and effective treatment plans for many patients. There are much promise and hype around precision medicine, but implementing and scaling a precision medicine program is challenging. Multiple disciplines must collaborate in order to reach an accurate diagnosis and effective treatment plans. Unfortunately, information is frequently in sales, disparate systems, or lost.

Clinical trial participants are no longer just numbers on a spreadsheet. They are customers, consumers, patients and people, with all their wonderful complexities, preferences and nuances. And they have a right to choose whether your trial is going to suit them.

Worldwide, there is a growing appeal in the pharmaceutical industry for recombinant technologies that help alleviate, and eventually replace, the use of animal resources for endotoxin testing purposes.

As we develop new methods to create more biologically relevant models for research in understanding disease etiology and innovating new treatment options, one of the most requested areas for educational materials is 3D cell models such as organoid and spheroid systems. Thermo Fisher Scientific is proud to present our webinar series on 3D culture & analysis, and more importantly, how you can get started, how to monitor and analyze 3D models and what to do with these once you have successfully cultured your organoid or spheroid model of interest. In this series we will specifically cover the following areas and after taking part in the presentations, hopefully you will be better equipped to answer the basic questions and feel enabled to get started using 3D culture systems.